Preventive measures include genetic counseling to determine carrier status of translocation or structural abnormality of the parent's chromosome 5 (5). This is obtained by cytogenic testing which is performed to analyze chromosomal structure, if translocation is present then the patient is considered a carrier. Prenatal testing is available for those suspected of carrying the translocated chromosome by performing an amniocentesis or chronic villus sampling (8). An amniocentesis can be done between weeks 15-20 of pregnancy, cells collected from the amniotic fluid can be analyzed for chromosomal abnormalities. Similar evaluation of chromosome structure can be done using a tissue sample obtained from the placenta during weeks 10-13 of pregnancy, referred to as chronic villus sampling. Individual's diagnosed with this genetic disease….prognosis
Preventive measures include genetic counseling to determine carrier status of translocation or structural abnormality of the parent's chromosome 5 (5). This is obtained by cytogenic testing which is performed to analyze chromosomal structure, if translocation is present then the patient is considered a carrier. Prenatal testing is available for those suspected of carrying the translocated chromosome by performing an amniocentesis or chronic villus sampling (8). An amniocentesis can be done between weeks 15-20 of pregnancy, cells collected from the amniotic fluid can be analyzed for chromosomal abnormalities. Similar evaluation of chromosome structure can be done using a tissue sample obtained from the placenta during weeks 10-13 of pregnancy, referred to as chronic villus sampling. Individual's diagnosed with this genetic disease….prognosis